Here's Why You Should Retain CONMED Stock in Your Portfolio for Now

Core Viewpoint - CONMED Corporation is positioned for growth due to its diverse product offerings and strong recurring revenue base, particularly in General Surgery, despite facing supply chain challenges and data security threats [1][2]. Group 1: Financial Performance - CONMED has a market capitalization of $2.26 billion and projects a 19.3$4.03 per share, with projected fourth-quarter revenues of $341.3 million, indicating growth of 4.3% year-over-year [12]. Group 2: Product and Market Position - CONMED's General Surgery segment is gaining traction with unique products like the Anchor Tissue Retrieval bag, contributing to a 3.6% revenue increase at constant exchange rates in Q3 2024 [4]. - The company has a broad product spectrum across various specialties, including orthopedics and gastroenterology, with key innovations like Hi-Fi Tape and the IM8000 surgical visualization system [6][7]. - Approximately 85% of CONMED's revenues come from recurring sales of single-use disposable products, which are increasingly preferred by healthcare facilities [8]. Group 3: Market Challenges - Supply chain constraints and data security threats are ongoing challenges for CONMED, potentially impacting operational stability and financial performance [1][11]. - The U.S. foot and ankle business may face sales declines due to the impact of hurricanes Helene and Milton, which caused procedure rescheduling [5].